Would homegrown LEN cost more? Why SA should still make the HIV prevention jab
South Africa aims to manufacture the revolutionary six-monthly HIV prevention injection lenacapavir locally. Experts weigh the need for rapid, affordable access against building long-term regional production capacity.
We haven't written up this one. Mail and Guardian has the full story — the link below goes straight to it.